Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants

J Infect. 2022 May;84(5):e55-e57. doi: 10.1016/j.jinf.2022.02.030. Epub 2022 Mar 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • SARS-CoV-2*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 Vaccine

Supplementary concepts

  • SARS-CoV-2 variants